Fenofibrate
- Product NDC
- 0615-7548
- 11-digit product format
- 006157548
- Labeler code
- 0615
- Product ID
- 0615-7548_bdda5eba-bfcc-42e3-834f-860e08d72d82
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- FENOFIBRATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA075868
- Marketing category
- ANDA
- Marketing start
- 2010-02-01
- Marketing end
- 0000-00-00
- Substance
- FENOFIBRATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7548-05 | 2021-05-14 | C162847 | 48780-1 | 9d75b9d0-b455-f424-e053-dadaa90a57ce | e5e78bfc-1b18-46fa-aebd-f8ae313960c1 |
| 0615-7548-31 | 2021-05-14 | C162847 | 48780-1 | 9d75b9d0-b455-f424-e053-dadaa90a57ce | e5e78bfc-1b18-46fa-aebd-f8ae313960c1 |
| 0615-7548-39 | 2021-05-14 | C162847 | 48780-1 | 9d75b9d0-b455-f424-e053-dadaa90a57ce | e5e78bfc-1b18-46fa-aebd-f8ae313960c1 |
| 0615-7548-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b455-f424-e053-dadaa90a57ce | e5e78bfc-1b18-46fa-aebd-f8ae313960c1 |
| 0615-7548-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b455-f424-e053-dadaa90a57ce | e5e78bfc-1b18-46fa-aebd-f8ae313960c1 |
| 0615-7548-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b455-f424-e053-dadaa90a57ce | e5e78bfc-1b18-46fa-aebd-f8ae313960c1 |